Welcome to our dedicated page for Becton Dickinson & Co news (Ticker: BDX), a resource for investors and traders seeking the latest updates and insights on Becton Dickinson & Co stock.
Becton, Dickinson and Company (NYSE: BDX) is a global leader in medical technology driving advancements in healthcare through innovative devices, diagnostic solutions, and clinical systems. This page provides real-time updates on BD's latest developments, offering investors and professionals a centralized hub for tracking corporate announcements and industry impact.
Access authoritative information including earnings reports, regulatory milestones, product innovations, and strategic partnerships. Our curated news collection helps stakeholders monitor BD's contributions to medication management, diagnostic testing, and surgical care across 190+ countries.
Key updates cover BD Medical safety-engineered products, BD Life Sciences diagnostic platforms, and BD Interventional surgical technologies. Stay informed about developments in smart medication systems, infectious disease testing, and minimally invasive procedures shaping modern healthcare.
Bookmark this page for ongoing insights into BD's operational updates, leadership changes, and R&D breakthroughs. Verify critical information directly through primary sources while maintaining awareness of market trends in the $600B+ medical technology sector.
BD reported strong financial results for the second quarter of fiscal 2024, with revenue increasing by 4.6%, GAAP and adjusted EPS growing by 20.9% and 10.8% respectively, and year-to-date cash flow improving significantly. The company raised its full-year adjusted EPS guidance and affirmed organic revenue growth guidance. BD's performance was driven by its diverse portfolio and focus on operational excellence.
The company's recent highlights include increasing domestic production of syringes, launching new products such as automated dispensing cabinet systems and cell sorters, and forming strategic partnerships to enhance healthcare solutions. BD also received recognition for innovation and employee well-being.
BD (Becton, Dickinson and Company) declares a quarterly dividend of $0.95 per common share, payable on June 28, 2024. The indicated annual dividend rate is $3.80 per share.
BD (Becton, Dickinson and Company) will be presenting at the Bank of America Securities Health Care Conference 2024 on May 14, 2024. The presentation will be live-streamed on BD's investor relations website.
FAQ
What is the current stock price of Becton Dickinson & Co (BDX)?
What is the market cap of Becton Dickinson & Co (BDX)?
